Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCQS Natural Resources Growth & Income Trust Regulatory News (CYN)

Share Price Information for CQS Natural Resources Growth & Income Trust (CYN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 188.75
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 1.50 (0.798%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 188.75
CYN Live PriceLast checked at -
CQS Natural Resources Growth & Income is an Investment Trust

To provide shareholders with capital growth and income predominantly from a portfolio of mining and resource equities and of mining, resource and industrial fixed interest securities.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transaction in Own Shares

30 Apr 2024 17:07

RNS Number : 6811M
CQS Natural Resources Grwth&Inc PLC
30 April 2024
 

For immediate release

30 April 2024

 

CQS Natural Resources Growth and Income PLC(the "Company")LEI: 549300ES8CNIK2CQR054

Market Purchase of Company's Own Shares

This notification is given pursuant to the authority granted at an Annual General Meeting of the Company held on 15 December 2023 to make market purchases of the Company's own shares up to an aggregate maximum of 10,026,587.

The Company has purchased a total of 23,250 Ordinary shares of 25p each in the capital of the Company today at a price of 186.00 pence per share. These shares will be held in treasury.

Following this transaction and in conformity with the provisions of the Transparency Directive, the Company hereby notifies the market that the resultant number of Ordinary shares held by the Company in treasury is 113,250 and the total number of Ordinary shares that the Company has in issue, including shares held in treasury, is 66,888,509. The total number of voting rights in the Company following the repurchase is 66,775,259.

The figure of 66,775,259 may be used by shareholders as the denominator for the calculation by which they may determine if they are required to notify their interest in, or change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.

-ENDS-

For further information please contact:

Administrator and Company SecretaryFrostrow Capital LLPEleanor CranmerEmail: cosec@frostrow.com Tel: 0203 008 4613

Investment ManagerManulife | CQS Investment Management

Craig ClelandEmail: contactncim@cqsm.com Tel: 0207 201 5368

Corporate Broker

Cavendish Capital Markets LimitedCorporate Finance: Tunga Chigovanyika / Will TalkingtonTel: 020 7220 0557Sales: Daniel Balabanoff / Pauline TribeTel: 020 7220 0500

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSIMMFTMTMJBFI
Date   Source Headline
25th Apr 202312:03 pmRNSNet Asset Value(s)
24th Apr 20232:34 pmRNSNet Asset Value(s)
21st Apr 20231:04 pmRNSNet Asset Value(s)
20th Apr 202312:47 pmRNSNet Asset Value(s)
19th Apr 20232:13 pmRNSNet Asset Value(s)
18th Apr 20231:17 pmRNSNet Asset Value(s)
17th Apr 20232:42 pmRNSNet Asset Value(s)
14th Apr 20234:47 pmRNSNet Asset Value(s)
13th Apr 20232:46 pmRNSNet Asset Value(s)
12th Apr 20233:15 pmRNSDividend Declaration
12th Apr 20232:33 pmRNSNet Asset Value(s)
11th Apr 202312:34 pmRNSNet Asset Value(s)
6th Apr 20231:50 pmRNSNet Asset Value(s)
5th Apr 20233:32 pmRNSNet Asset Value(s)
4th Apr 20232:19 pmRNSNet Asset Value(s)
3rd Apr 20234:17 pmRNSNet Asset Value(s)
31st Mar 20232:30 pmRNSNet Asset Value(s)
30th Mar 20233:41 pmRNSNet Asset Value(s)
29th Mar 20232:58 pmRNSNet Asset Value(s)
28th Mar 20234:57 pmRNSNet Asset Value(s)
27th Mar 20232:43 pmRNSNet Asset Value(s)
24th Mar 20231:36 pmRNSNet Asset Value(s)
23rd Mar 20232:07 pmRNSNet Asset Value(s)
22nd Mar 20233:36 pmRNSHalf-year Report - Replacement
22nd Mar 20232:52 pmRNSHalf-year Report
22nd Mar 20231:15 pmRNSNet Asset Value(s)
21st Mar 20232:11 pmRNSNet Asset Value(s)
20th Mar 202311:47 amRNSNet Asset Value(s)
17th Mar 20234:59 pmRNSMonthly Factsheet
17th Mar 20233:02 pmRNSNet Asset Value(s)
16th Mar 20233:15 pmRNSNet Asset Value(s)
16th Mar 202312:06 pmRNSHolding(s) in Company
15th Mar 20233:19 pmRNSNet Asset Value(s)
14th Mar 20235:07 pmRNSNet Asset Value(s)
13th Mar 202312:53 pmRNSNet Asset Value(s)
10th Mar 20233:18 pmRNSNet Asset Value(s)
9th Mar 20232:44 pmRNSNet Asset Value(s)
8th Mar 20233:06 pmRNSNet Asset Value(s)
7th Mar 20232:27 pmRNSNet Asset Value(s)
6th Mar 20232:18 pmRNSNet Asset Value(s)
3rd Mar 20231:17 pmRNSNet Asset Value(s)
2nd Mar 20232:38 pmRNSNet Asset Value(s)
1st Mar 20232:18 pmRNSNet Asset Value(s)
28th Feb 202312:53 pmRNSNet Asset Value(s)
27th Feb 20233:03 pmRNSNet Asset Value(s)
24th Feb 20232:42 pmRNSNet Asset Value(s)
23rd Feb 202312:17 pmRNSNet Asset Value(s)
22nd Feb 20231:32 pmRNSNet Asset Value(s)
21st Feb 20231:43 pmRNSNet Asset Value(s)
20th Feb 20233:31 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.